Dan Wygal
Vice President, US Corporate Affairs
Responsibilities
Dan leads the US Corporate Affairs team and is responsible for communications, government affairs, policy and patient advocacy across AstraZeneca’s BioPharmaceutical Business Unit and Oncology Business Unit. He serves as a member of the US Leadership Team.
Prior Experience
Before assuming his current role in 2023, he was Country President of AstraZeneca Ireland since 2021. Dan joined AstraZeneca in 2004 and has held various leadership roles, including Executive Director, Value Strategy within the US Market Access Team, where he oversaw the development and delivery of innovative value strategies, gross-to-net contract, and channel strategies for US Oncology and BioPharmaceutical Business Units.
Additionally, he held roles within Market Access, Marketing, and Sales Leadership at AstraZeneca, MedImmune, and GSK.
Education
- Bachelor of Science Degree, Business, State University of New York, Oswego
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
Use a maximum of two downloads here